Lecture 3 Survival analysis. Problem Do patients survive longer after treatment A than after treatment B? Possible solutions: –ANOVA on mean survival.

Slides:



Advertisements
Similar presentations
Survival Analysis. Key variable = time until some event time from treatment to death time for a fracture to heal time from surgery to relapse.
Advertisements

X Treatment population Control population 0 Examples: Drug vs. Placebo, Drugs vs. Surgery, New Tx vs. Standard Tx Let X = decrease (–) in cholesterol.
Survival Analysis-1 In Survival Analysis the outcome of interest is time to an event In Survival Analysis the outcome of interest is time to an event The.
Survival Analysis. Statistical methods for analyzing longitudinal data on the occurrence of events. Events may include death, injury, onset of illness,
Introduction to Survival Analysis October 19, 2004 Brian F. Gage, MD, MSc with thanks to Bing Ho, MD, MPH Division of General Medical Sciences.
Departments of Medicine and Biostatistics
April 25 Exam April 27 (bring calculator with exp) Cox-Regression
Intermediate methods in observational epidemiology 2008 Instructor: Moyses Szklo Measures of Disease Frequency.
Ch. 28 Chi-square test Used when the data are frequencies (counts) or proportions for 2 or more groups. Example 1.
Biostatistics in Research Practice Time to event data Martin Bland Professor of Health Statistics University of York
Chapter 11 Survival Analysis Part 2. 2 Survival Analysis and Regression Combine lots of information Combine lots of information Look at several variables.
Main Points to be Covered Cumulative incidence using life table method Difference between cumulative incidence based on proportion of persons at risk and.
Measures of disease frequency (I). MEASURES OF DISEASE FREQUENCY Absolute measures of disease frequency: –Incidence –Prevalence –Odds Measures of association:
Survival analysis. First example of the day Small cell lungcanser Meadian survival time: 8-10 months 2-year survival is 10% New treatment showed median.
Analysis of Complex Survey Data
Survival Analysis Diane Stockton. Survival Curves Y axis, gives the proportion of people surviving from 1 at the top to zero at the bottom, representing.
Kaplan-Meier Estimation &Log-Rank Test Survival of Ventilated and Control Flies (Old Falmouth Line 107) R.Pearl and S.L. Parker (1922). “Experimental Studies.
Survival analysis Brian Healy, PhD. Previous classes Regression Regression –Linear regression –Multiple regression –Logistic regression.
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 10: Survival Curves Marshall University Genomics Core.
HSTAT1101: 27. oktober 2004 Odd Aalen
01/20141 EPI 5344: Survival Analysis in Epidemiology Quick Review and Intro to Smoothing Methods March 4, 2014 Dr. N. Birkett, Department of Epidemiology.
Statistics for clinical research An introductory course.
Essentials of survival analysis How to practice evidence based oncology European School of Oncology July 2004 Antwerp, Belgium Dr. Iztok Hozo Professor.
1 Survival Analysis Biomedical Applications Halifax SAS User Group April 29/2011.
HSRP 734: Advanced Statistical Methods July 10, 2008.
Dr Laura Bonnett Department of Biostatistics. UNDERSTANDING SURVIVAL ANALYSIS.
Lecture 3 Survival analysis.
Estimation of Various Population Parameters Point Estimation and Confidence Intervals Dr. M. H. Rahbar Professor of Biostatistics Department of Epidemiology.
1 Introduction to medical survival analysis John Pearson Biostatistics consultant University of Otago Canterbury 7 October 2008.
Design and Analysis of Clinical Study 11. Analysis of Cohort Study Dr. Tuan V. Nguyen Garvan Institute of Medical Research Sydney, Australia.
SIMPLE TWO GROUP TESTS Prof Peter T Donnan Prof Peter T Donnan.
X Treatment population Control population 0 Examples: Drug vs. Placebo, Drugs vs. Surgery, New Tx vs. Standard Tx  Let X =  cholesterol level (mg/dL);
Repeated measures ANOVA in SPSS Cross tabulations Survival analysis.
INTRODUCTION TO SURVIVAL ANALYSIS
Chapter 12 Survival Analysis.
Statistical Inference for more than two groups Peter T. Donnan Professor of Epidemiology and Biostatistics Statistics for Health Research.
Essential Statistics Chapter 161 Review Part III_A_Chi Z-procedure Vs t-procedure.
Introduction Sample Size Calculation for Comparing Strategies in Two-Stage Randomizations with Censored Data Zhiguo Li and Susan Murphy Institute for Social.
Lecture 5: The Natural History of Disease: Ways to Express Prognosis
01/20151 EPI 5344: Survival Analysis in Epidemiology Actuarial and Kaplan-Meier methods February 24, 2015 Dr. N. Birkett, School of Epidemiology, Public.
Non-parametric Tests e.g., Chi-Square. When to use various statistics n Parametric n Interval or ratio data n Name parametric tests we covered Tuesday.
Biostatistics Case Studies 2014 Youngju Pak Biostatistician Session 5: Survival Analysis Fundamentals.
1 Always be mindful of the kindness and not the faults of others.
Biostatistics Case Studies 2007 Peter D. Christenson Biostatistician Session 2: Aging and Survival.
01/20151 EPI 5344: Survival Analysis in Epidemiology Quick Review from Session #1 March 3, 2015 Dr. N. Birkett, School of Epidemiology, Public Health &
X Treatment population Control population 0 Examples: Drug vs. Placebo, Drugs vs. Surgery, New Tx vs. Standard Tx  Let X = decrease (–) in cholesterol.
Some survival basics Developments from the Kaplan-Meier method October
Section 6.4 Inferences for Variances. Chi-square probability densities.
INTRODUCTION TO CLINICAL RESEARCH Survival Analysis – Getting Started Karen Bandeen-Roche, Ph.D. July 20, 2010.
Biostatistics Case Studies 2009 Peter D. Christenson Biostatistician Session 2: Survival Analysis Fundamentals.
SURVIVAL ANALYSIS PRESENTED BY: DR SANJAYA KUMAR SAHOO PGT,AIIH&PH,KOLKATA.
Marshall University School of Medicine Department of Biochemistry and Microbiology BMS 617 Lecture 16 : Summary Marshall University Genomics Core Facility.
Methods and Statistical analysis. A brief presentation. Markos Kashiouris, M.D.
1 Analysis of Survival Data with Demographic Applications (Spring term 2006) Lecture 3: Non-Parametric Comparison of two or more Survival Curves.
Carolinas Medical Center, Charlotte, NC Website:
April 18 Intro to survival analysis Le 11.1 – 11.2
Survival Analysis Rick Chappell, Ph.D. Professor,
Statistical Inference for more than two groups
Statistics 103 Monday, July 10, 2017.
Saturday, August 06, 2016 Farrokh Alemi, PhD.
Jeffrey E. Korte, PhD BMTRY 747: Foundations of Epidemiology II
Chapter 13 Group Differences
Mintu P. Turakhia et al. JACEP 2016;2:
Chapter 4 SURVIVAL AND LIFE TABLES
Where are we?.
Anaplastic Lymphoma Kinase Gene Rearrangements in Non-small Cell Lung Cancer are Associated with Prolonged Progression-Free Survival on Pemetrexed  D.
MiR-520d-3p is an independent positive prognostic factor in ovarian cancer. miR-520d-3p is an independent positive prognostic factor in ovarian cancer.
Progression-free (a) and overall (b) survival by age subgroup, Kaplan-Meier plots. Progression-free (a) and overall (b) survival by age subgroup, Kaplan-Meier.
Kaplan-Meier survival curves and the log rank test
Cumulative probability of CIN2 stratified by HPV test results.
Presentation transcript:

Lecture 3 Survival analysis

Problem Do patients survive longer after treatment A than after treatment B? Possible solutions: –ANOVA on mean survival time? –ANOVA on median survival time?

Progressively censored observations Current life table –Completed dataset Cohort life table –Analysis “on the fly”

First example of the day

Person-year of observation In total: days ~ 41.4y 11 patients died: 11/41.4y = y death/100y 1000 patients in 1 y or 100 patients in 10y

Mortality rates 11 of 25 patients died 11/25 = 44% When is the analysis done?

1-year survival rate 6 patients dies the first year 25 patients started 24%

1-year survival rate 3 patients less than 1 year 6/(25-3) = 27% Patient 7 24% -27%

Actuarial / life table anelysis Treatment for lung cancer

Actuarial / life table anelysis A sub-set of 13 patients undergoing the same treatment

Actuarial / life table anelysis Time interval chosen to be 3 months n i number of patients starting a given period

Actuarial / life table anelysis d i number of terminal events, in this example; progression/response w i number of patients that have not yet been in the study long enough to finish this period

Actuarial / life table anelysis Number exposed to risk: n i – w i /2 Assuming that patients withdraw in the middle of the period on average.

Actuarial / life table anelysis q i = d i /(n i – w i /2) Proportion of patients terminating in the period

Actuarial / life table anelysis p i = 1 - q i Proportion of patients surviving

Actuarial / life table anelysis S i = p i p i-1...p i-N Cumulative proportion of surviving Conditional probability

Survival curves How long will a lung canser patient survive on this particular treatment?

Kaplan-Meier Simple example with only 2 ”terminal-events”.

Confidence interval of the Kaplan- Meier method Fx after 32 months

Confidence interval of the Kaplan- Meier method Survival plot for all data on treatment 1 Are there differences between the treatments?

Comparing Two Survival Curves One could use the confidence intervals… But what if the confidence intervals are not overlapping only at some points? Logrank-stats –Hazard ratio Mantel-Haenszel methods

Comparing Two Survival Curves The logrank statistics Aka Mantel-logrank statistics Aka Cox-Mantel-logrank statistics

Comparing Two Survival Curves Five steps to the logrank statistics table 1.Divide the data into intervals (eg. 10 months) 2.Count the number of patients at risk in the groups and in total 3.Count the number of terminal events in the groups and in total 4.Calculate the expected numbers of terminal events e.g. (31-40) 44 in grp1 and 46 in grp2, 4 terminal events. expected terminal events 4x(44/90) and 4x(46/90) 5.Calculate the total

Comparing Two Survival Curves Smells like Chi-Square statistics

Comparing Two Survival Curves Hazard ratio

Comparing Two Survival Curves Mantel Haenszel test Is the OR significant different from 1? Look at cell (1,1) Estimated value, E(a i ) Variance, V(a i ) row total * column total grand total

Comparing Two Survival Curves Mantel Haenszel test df = 1; p>0.05

Hazard function d is the number of terminal events  f is the sum of failure times  c is the sum of censured times